Cite
HARVARD Citation
van der Meulen, M. et al. (n.d.). OS7.1 Impact of the addition of Rituximab to standard therapy with high dose methotrexate on health-related quality of life in primary central nervous system lymphoma patients. Neuro-oncology. pp. iii13-iii14. [Online].